The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Real-world comparative effectiveness and cardiovascular safety of enzalutamide versus abiraterone amongst older men diagnosed with metastatic castration-resistant prostate cancer.

Charles  Gaber

Research Funding - Abbvie (Inst)

Ebere  Okpara

No Relationships to Disclose

Abdullah  Abdelaziz

No Relationships to Disclose

Jyotirmoy  Sarker

Employment - Abbvie; Merck

Kent  Hanson

Consulting or Advisory Role - Pfizer

Lubna  Hassan

Employment - Abbvie

Fang-Ju  Lin

Research Funding - Boehringer Ingelheim; Novartis

Todd  Lee

Honoraria - Optum Rx

Expert Testimony - Cook Medical

Natalie Marie  Reizine

Consulting or Advisory Role - Curium Pharma; Tempus

Speakers' Bureau - AstraZeneca; EMD Serono; Janssen Oncology; Merck; Tempus